Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02349061
Brief Title: A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

First Submitted : January 23, 2015
First Submitted that Met QC Criteria : January 23, 2015
First Posted : January 28, 2015 (Estimate)

Results First Submitted : May 15, 2018
Results First Submitted that Met QC Criteria : May 15, 2018
Results First Posted : June 12, 2018

Last Update Submitted that Met QC Criteria : March 11, 2020
Last Update Posted : March 24, 2020